Cargando…
PM00104 (Zalypsis(®)): A Marine Derived Alkylating Agent
PM00104 (Zalypsis(®)) is a synthethic tetrahydroisoquinolone alkaloid, which is structurally similar to many marine organisms. The compound has been proposed as a potential chemotherapeutic agent in the treatment of solid human tumors and hematological malignancies. PM00104 is a DNA binding agent, c...
Autores principales: | Petek, Bradley J., Jones, Robin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270769/ https://www.ncbi.nlm.nih.gov/pubmed/25153860 http://dx.doi.org/10.3390/molecules190812328 |
Ejemplares similares
-
ZNF93 Increases Resistance to ET-743 (Trabectedin; Yondelis®) and PM00104 (Zalypsis®) in Human Cancer Cell Lines
por: Duan, Zhenfeng, et al.
Publicado: (2009) -
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours
por: Yap, T A, et al.
Publicado: (2012) -
Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis
por: Moneo, Victoria, et al.
Publicado: (2014) -
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019) -
Alkylating anticancer agents and their relations to microRNAs
por: Biersack, Bernhard
Publicado: (2019)